Customized Novel Design of 3D Printed Pregabalin Tablets for Intra-Gastric Floating and Controlled Release Using Fused Deposition Modeling
Tóm tắt
Three-dimensional (3D) printing has been recently employed in the design and formulation of various dosage forms with the aim of on-demand manufacturing and personalized medicine. In this study, we formulated a floating sustained release system using fused deposition modeling (FDM). Filaments were prepared using hypromellose acetate succinate (HPMCAS), polyethylene glycol (PEG 400) and pregabalin as the active ingredient. Cylindrical tablets with infill percentages of 25%, 50% and 75% were designed and printed with the FDM printer. An optimized formulation (F6) was designed with a closed bottom layer and a partially opened top layer. Filaments and tablets were characterized by means of fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD), and thermogravimetric analysis (TGA). The results show that the processing condition did not have a significant effect on the stability of the drug and the crystallinity of the drug remained even after printing. A dissolution study revealed that drug release is faster in an open system with low infill percentage compared to closed systems and open systems with a high infill ratio. The optimized formulation (F6) with partially opened top layer showed zero-order drug release. The results show that FDM printing is suitable for the formulation of floating dosage form with the desired drug release profile.
Từ khóa
Tài liệu tham khảo
Kodama, 1981, Automatic method for fabricating a three-dimensional plastic model with photo-hardening polymer, Rev. Sci. Instrum., 52, 1770, 10.1063/1.1136492
Cohen, 2009, Mandibular reconstruction using stereolithographic 3-dimensional printing modeling technology, Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endodontology, 108, 661, 10.1016/j.tripleo.2009.05.023
Trenfield, 2018, 3D Printing Pharmaceuticals: Drug Development to Frontline Care, Trends Pharm. Sci., 39, 440, 10.1016/j.tips.2018.02.006
Lamichhane, 2019, Complex formulations, simple techniques: Can 3D printing technology be the Midas touch in pharmaceutical industry?, Asian J. Pharm. Sci., 14, 465, 10.1016/j.ajps.2018.11.008
Attaran, 2017, The rise of 3-D printing: The advantages of additive manufacturing over traditional manufacturing, Bus. Horiz., 60, 677, 10.1016/j.bushor.2017.05.011
Park, B.J., Choi, H.J., Moon, S.J., Kim, S.J., Bajracharya, R., Min, J.Y., and Han, H.-K. (2018). Pharmaceutical applications of 3D printing technology: current understanding and future perspectives. J. Pharm. Investig.
Yao, 2016, Three-dimensional printing: review of application in medicine and hepatic surgery, Cancer Biol. Med., 13, 443, 10.20892/j.issn.2095-3941.2016.0075
Fina, 2018, 3D printing of drug-loaded gyroid lattices using selective laser sintering, Int. J. Pharm., 547, 44, 10.1016/j.ijpharm.2018.05.044
Fina, 2017, Selective laser sintering (SLS) 3D printing of medicines, Int. J. Pharm., 529, 285, 10.1016/j.ijpharm.2017.06.082
Fina, 2018, Fabricating 3D printed orally disintegrating printlets using selective laser sintering, Int. Pharm., 541, 101, 10.1016/j.ijpharm.2018.02.015
Mohamed, 2019, Understanding the effects of formulation and process variables on the printlets quality manufactured by selective laser sintering 3D printing, Int. J. Pharm., 570, 118651, 10.1016/j.ijpharm.2019.118651
Wu, 1996, Solid free-form fabrication of drug delivery devices, J. Control. Release, 40, 77, 10.1016/0168-3659(95)00173-5
Joo, Y., Shin, I., Ham, G., Abuzar, S.M., Hyun, S.-M., and Hwang, S.-J. (2019). The advent of a novel manufacturing technology in pharmaceutics: Superiority of fused deposition modeling 3D printer. J. Pharm. Investig.
Norman, 2017, A new chapter in pharmaceutical manufacturing: 3D-printed drug products, Adv. Drug Deliv. Rev., 108, 39, 10.1016/j.addr.2016.03.001
Goyanes, 2016, 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems, J. Control. Release, 234, 41, 10.1016/j.jconrel.2016.05.034
Pietrzak, 2015, A flexible-dose dispenser for immediate and extended release 3D printed tablets, Eur. J. Pharm. Biopharm., 96, 380, 10.1016/j.ejpb.2015.07.027
Melocchi, 2016, Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling, Int. J. Pharm., 509, 255, 10.1016/j.ijpharm.2016.05.036
Goyanes, 2014, Fused-filament 3D printing (3DP) for fabrication of tablets, Int. J. Pharm., 476, 88, 10.1016/j.ijpharm.2014.09.044
Goyanes, 2015, Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing, Int. J. Pharm., 496, 414, 10.1016/j.ijpharm.2015.10.039
Skowyra, 2015, Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing, Eur. J. Pharm. Sci., 68, 11, 10.1016/j.ejps.2014.11.009
Kurek, 2017, 3D printed orodispersible films with Aripiprazole, Int. J. Pharm., 533, 413, 10.1016/j.ijpharm.2017.05.052
Goyanes, 2019, Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process, Int. J. Pharm., 567, 118471, 10.1016/j.ijpharm.2019.118471
Carlier, 2019, Investigation of the parameters used in fused deposition modeling of poly(lactic acid) to optimize 3D printing sessions, Int. J. Pharm., 565, 367, 10.1016/j.ijpharm.2019.05.008
Nober, 2019, Feasibility study into the potential use of fused-deposition modeling to manufacture 3D-printed enteric capsules in compounding pharmacies, Int. J. Pharm., 569, 118581, 10.1016/j.ijpharm.2019.118581
Rosenstock, 2004, Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial, Pain, 110, 628, 10.1016/j.pain.2004.05.001
Crofford, 2005, Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial, Arthritis Rheum, 52, 1264, 10.1002/art.20983
Kim, 2018, Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics, Int. J. Pharm., 550, 160, 10.1016/j.ijpharm.2018.08.038
Bockbrader, 2010, Clinical pharmacokinetics of pregabalin in healthy volunteers, J. Clin. Pharmacol., 50, 941, 10.1177/0091270009352087
Huffman, 2017, Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia, Clin. J. Pain, 33, 569, 10.1097/AJP.0000000000000445
Qin, 2018, Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation, Int. J. Pharm., 545, 37, 10.1016/j.ijpharm.2018.04.011
Chai, 2017, Fused deposition modeling (FDM) 3D printed tablets for intragastric floating delivery of domperidone, Sci. Rep., 7, 2829, 10.1038/s41598-017-03097-x
Li, 2015, Preparation and characterization of azithromycin–Aerosil 200 solid dispersions with enhanced physical stability, Int. J. Pharm., 486, 175, 10.1016/j.ijpharm.2015.03.029
Dash, 2010, Kinetic modeling on drug release from controlled drug delivery systems, Acta Pol. Pharm., 67, 217
Gibaldi, 1967, Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms, J. Pharm. Sci., 56, 1238, 10.1002/jps.2600561005
Bloomquist, 2018, Controlling release from 3D printed medical devices using CLIP and drug-loaded liquid resins, J. Control. Release, 278, 9, 10.1016/j.jconrel.2018.03.026
Higuchi, 1963, Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci., 52, 1145, 10.1002/jps.2600521210
Hixson, 1931, Dependence of reaction velocity upon surface and agitation, Ind. Eng. Chem., 23, 923, 10.1021/ie50260a018
Anderson, 1998, An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles, J. Pharm. Biomed. Anal., 17, 811, 10.1016/S0731-7085(98)00011-9
Costa, 2001, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci., 13, 123, 10.1016/S0928-0987(01)00095-1
Repka, 2007, Pharmaceutical applications of hot-melt extrusion: Part II, Drug Dev. Ind. Pharm., 33, 1043, 10.1080/03639040701525627
Zhang, 2017, Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets, Int. J. Pharm., 519, 186, 10.1016/j.ijpharm.2016.12.049
Melocchi, 2015, 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs, J. Drug Deliv. Sci. Technol., 30, 360, 10.1016/j.jddst.2015.07.016
Salaman, C.R.P., Tesson, N., Castano, M.T., and Romana, L.C. (2011). Crystalline forms of pregabalin and co-formers in the treatment of pain. (EP 2 527 319 A1), European Patent.
Goyanes, 2015, 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets, Eur. J. Pharm. Biopharm., 89, 157, 10.1016/j.ejpb.2014.12.003
Goyanes, 2017, Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing, Int. J. Pharm., 527, 21, 10.1016/j.ijpharm.2017.05.021
Moscato, 2016, Infill-dependent 3-D-printed material based on NinjaFlex filament for antenna applications, IEEE Antennas Wirel. Propag. Lett., 15, 1506, 10.1109/LAWP.2016.2516101
Goyanes, 2015, Effect of geometry on drug release from 3D printed tablets, Int. J. Pharm., 494, 657, 10.1016/j.ijpharm.2015.04.069